首批创新浮动费率基金明日起发售；66只医药主题基金年内涨超20%

Group 1: Fund News - The first batch of innovative floating rate funds will be launched starting May 27, following their approval last week [1] - 66 pharmaceutical-themed funds have increased by over 20% this year, with 251 out of 282 funds showing positive performance [1] - The Hong Kong-themed fund, Huatai-PB Hong Kong Advantage Selected Fund, has topped the performance rankings among public funds, with over 1,100 funds holding more than 20% of their net asset value in Hong Kong stocks showing positive returns this year [1] Group 2: Market Insights - The Hong Kong stock market has become one of the best-performing technology markets globally this year, driven by strong fundamentals and low valuations, according to fund manager Wang Guizhong [1] - The macro theme for this year is expected to be "recovery," with technology sectors, particularly AI, presenting nonlinear growth opportunities [1] - The IPO market in Hong Kong is anticipated to see a significant recovery in 2025, indicating substantial future investment opportunities [1] Group 3: ETF Market Review - The market experienced fluctuations, with the Shanghai Composite Index down by 0.05% and the Shenzhen Component Index down by 0.41%, with a total trading volume of 1.01 trillion yuan [2] - The S&P 500 ETF led the gains with an increase of 3.22%, while gaming and big data ETFs also performed well [2] Group 4: ETF Opportunities - The importance of network and information security is expected to grow, with related expenditures projected to maintain a high growth rate, suggesting potential investment in information security ETFs and big data ETFs [5]